FEROZ Pharmaceuticals: Major
Health Technology
Mkt Cap
16.2B
P/E (TTM)
17.23
EPS
17.86
ROE
7.50%
Div Yield
1.07%
About
Ferozsons Laboratories Ltd. is a holding company, which engages in the manufacture and sale of pharmaceuticals and other related products. It operates through the following segments: Ferozsons, BF Biosciences, and Others. The Ferozsons segment is involved in the import, manufacture, and sale of pharmaceutical products as well as the distribution of medical devices. The BF Biosciences segment includes the development and provision of pharmaceutical products. The Others segment focuses on offering pharmaceutical and other related products. The company was founded on January 28, 1954 and is headquartered in Lahore, Pakistan.
Financial Highlights
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | ||
|---|---|---|---|---|---|---|
| Revenue | 18.86B | 15.85B | 11.46B | 9.33B | 8.88B | |
| Gross Profit | 7.63B | 6.20B | 4.11B | 3.80B | 3.47B | |
| Net Income | 776.54M | 683.15M | 271.27M | 734.43M | 1.17B | |
| EPS | 17.86 | 15.72 | 6.24 | 16.90 | 27.00 | |
| ROE | 6.58% | 7.14% | 3.46% | 9.64% | 16.89% | |
| ROA | 3.31% | 3.54% | 1.77% | 5.65% | 11.20% | |
| Gross Margin | 40.45% | 39.13% | 35.84% | 40.77% | 39.11% | |
| Net Margin | 4.12% | 4.31% | 2.37% | 7.87% | 13.22% | |
| Current Ratio | 1.94 | 1.61 | 1.55 | 2.29 | 2.81 | |
| DPS | 4.00 | 3.00 | 0.00 | 4.17 | 8.33 | |
| Free Cash Flow | 235.05M | -1.58B | -2.91B | -1.30B | 585.13M |